Eosinophilic Granulomatosis With Polyangiitis Clinical Trial
Official title:
A 52-week, Randomized, Double-blind, Double-dummy, Parallel-group, Multi-centre, Non-inferiority Study to Investigate the Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Receiving Standard of Care (SoC) Therapy
This study aims to investigate the efficacy and safety of depemokimab compared with mepolizumab in adults with relapsing or refractory EGPA receiving SoC therapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02967068 -
VCRC Tissue Repository
|
||
| Recruiting |
NCT05979051 -
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05030155 -
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
|
Phase 3 | |
| Active, not recruiting |
NCT03164473 -
Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
|
Phase 3 | |
| Recruiting |
NCT02006134 -
Pediatric Vasculitis Initiative
|
||
| Recruiting |
NCT06046222 -
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
|
Phase 2 | |
| Completed |
NCT04280601 -
PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis
|
N/A | |
| Not yet recruiting |
NCT06231498 -
The Epigenomic Signature of Eosinophilic Granulomatosis With Polyangiitis
|
||
| Recruiting |
NCT00315380 -
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
|
||
| Completed |
NCT03298061 -
Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
|
Phase 3 |